Cesium carbonate → 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-2,3,8-trimethylquinoline

HRID 1618629Notes

Reaction equation

HRID 1618629 reaction equation
[CH3:1][C:2]1([CH3:17])[C:10]2[C:5](=[CH:6][C:7]([N:11]3[CH2:16][CH2:15][O:14][CH2:13][CH2:12]3)=[CH:8][CH:9]=2)[NH:4][CH2:3]1.Cl[C:19]1[C:28]2[C:23](=[C:24]([CH3:29])[CH:25]=[CH:26][CH:27]=2)[N:22]=[C:21]([CH3:30])[C:20]=1[CH3:31].C(=O)([O-])[O-].[Cs+].[Cs+].C1C=CC(P(C2C(C3C(P(C4C=CC=CC=4)C4C=CC=CC=4)=CC=C4C=3C=CC=C4)=C3C(C=CC=C3)=CC=2)C2C=CC=CC=2)=CC=1>O1CCOCC1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.[Pd].[Pd]>[CH3:1][C:2]1([CH3:17])[C:10]2[C:5](=[CH:6][C:7]([N:11]3[CH2:16][CH2:15][O:14][CH2:13][CH2:12]3)=[CH:8][CH:9]=2)[N:4]([C:19]2[C:28]3[C:23](=[C:24]([CH3:29])[CH:25]=[CH:26][CH:27]=3)[N:22]=[C:21]([CH3:30])[C:20]=2[CH3:31])[CH2:3]1

Participants

7

Procedure

Prepared according to procedure T using 4-(3,3-dimethylindolin-6-yl)morpholine (0.151 g, 0.65 mmol), 4-chloro-2,3,8-trimethylquinoline (0.267 g, 1.3 mmol), cesium carbonate (0.424 g, 1.3 mmol), Pd2(dba)3 (0.060 g, 0.065 mmol) and (±) BINAP (0.061 g, 0.098 mmol) were added together in 1,4-dioxane (2 mL). Crude residue was purified via HPLC to give 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-2,3,8-trimethylquinoline. 1H NMR (400 MHz, DMSO-d6) δ ppm 7.40 (1H, d, J=7.8 Hz), 7.34 (1H, d, J=7.0 Hz), 7.17 (1H, m), 6.85 (1H, d, J=8.2 Hz), 6.04 (1H, dd, J=8.0, 2.2 Hz), 5.20 (1H, d, J=2.3 Hz), 3.50 (1H, d, J=9.0 Hz), 3.39 (5H, m), 2.63 (4H, dd, J=5.9, 3.9 Hz), 2.54 (3H, s), 2.52 (3H, s), 2.04 (3H, s), 1.26 (3H, s), 1.21 (3H, s). Mass Spectrum (ESI) m/e=407 (M+1).

Workup

  1. customPrepared
  2. customCrude residue was purified via HPLC

Sources & evidence

ORD record
ord-54ab252dec994859ad218a7d41632ee3
Source dataset
uspto-grants-2014_07
Patent number
US08765940B2

Reaction notes

Loading…